These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35660037)

  • 1. Comparison of performance of varicella vaccines via infectious disease modeling.
    Pillsbury M; Carias C; Samant S; Greenberg D; Pawaskar M
    Vaccine; 2022 Jun; 40(29):3954-3962. PubMed ID: 35660037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative efficacy of varicella vaccines: network meta-analysis of randomized controlled trials.
    Pawaskar M; Siddiqui MK; Takyar J; Sharma A; Fergie J
    Curr Med Res Opin; 2022 Oct; 38(10):1772-1782. PubMed ID: 35713564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The health and economic impact of switching vaccines in universal varicella vaccination programs using a dynamic transmission model: An Israel case study.
    Kujawski SA; Burgess C; Agi O; Attias-Geva Z; Pillsbury M; Greenberg D; Bencina G; Pawaskar M
    Hum Vaccin Immunother; 2022 Nov; 18(6):2124784. PubMed ID: 36315970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial.
    Povey M; Henry O; Riise Bergsaker MA; Chlibek R; Esposito S; Flodmark CE; Gothefors L; Man S; Silfverdal SA; Štefkovičová M; Usonis V; Wysocki J; Gillard P; Prymula R
    Lancet Infect Dis; 2019 Mar; 19(3):287-297. PubMed ID: 30765242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program.
    Quinn HE; Gidding HF; Marshall HS; Booy R; Elliott EJ; Richmond P; Crawford N; McIntyre PB; Macartney KK;
    J Infect; 2019 Mar; 78(3):220-225. PubMed ID: 30528868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling.
    Suh J; Choi JK; Lee J; Park SH
    Hum Vaccin Immunother; 2022 Nov; 18(5):2085468. PubMed ID: 35704399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel.
    Sheffer R; Segal D; Rahamani S; Dalal I; Linhart Y; Stein M; Shohat T; Somekh E
    Pediatr Infect Dis J; 2005 May; 24(5):434-7. PubMed ID: 15876943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children.
    Shinefield HR; Black SB; Staehle BO; Matthews H; Adelman T; Ensor K; Li S; Chan I; Heyse J; Waters M; Chan CY; Vessey SJ; Kaplan KM; Kuter BJ;
    Pediatr Infect Dis J; 2002 Jun; 21(6):555-61. PubMed ID: 12182381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical and economic costs associated with regional disparities in varicella vaccine coverage in Italy over 50 years (2020-2070).
    Lang JC; Samant S; Cook JR; Ranjan S; Senese F; Starnino S; Giuffrida S; Azzari C; Baldo V; Pawaskar M
    Sci Rep; 2024 May; 14(1):11929. PubMed ID: 38789451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effectiveness of Varicella Vaccine: 25 Years of Postlicensure Experience in the United States.
    Shapiro ED; Marin M
    J Infect Dis; 2022 Oct; 226(Suppl 4):S425-S430. PubMed ID: 36265844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological Impact and Cost-Effectiveness of Varicella Vaccination Strategies in the United Kingdom.
    Akpo EIH; Cristeau O; Hunjan M; Casabona G
    Clin Infect Dis; 2021 Dec; 73(11):e3617-e3626. PubMed ID: 33173938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of varicella vaccination in children in Germany: a case-control study.
    Liese JG; Cohen C; Rack A; Pirzer K; Eber S; Blum M; Greenberg M; Streng A
    Pediatr Infect Dis J; 2013 Sep; 32(9):998-1004. PubMed ID: 23694831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of healthy adults with live attenuated varicella vaccine.
    Gershon AA; Steinberg SP; LaRussa P; Ferrara A; Hammerschlag M; Gelb L
    J Infect Dis; 1988 Jul; 158(1):132-7. PubMed ID: 2839577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
    Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of protection against varicella in a randomized Phase III varicella-containing vaccine efficacy trial in healthy infants.
    Habib MA; Prymula R; Carryn S; Esposito S; Henry O; Ravault S; Usonis V; Wysocki J; Gillard P; Povey M
    Vaccine; 2021 Jun; 39(25):3445-3454. PubMed ID: 33736915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella breakthrough infection and effectiveness of 2-dose varicella vaccine in China.
    Pan X; Shu M; Ma R; Fang T; Dong H; Sun Y; Xu G
    Vaccine; 2018 Sep; 36(37):5665-5670. PubMed ID: 30104113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life.
    Henry O; Brzostek J; Czajka H; Leviniene G; Reshetko O; Gasparini R; Pazdiora P; Plesca D; Desole MG; Kevalas R; Gabutti G; Povey M; Innis B
    Vaccine; 2018 Jan; 36(3):381-387. PubMed ID: 29224964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Long-Term Clinical and Economic Impact of Universal Varicella Vaccination in Slovenia.
    Burgess C; Kujawski S; Lapornik A; Bencina G; Pawaskar M
    J Health Econ Outcomes Res; 2022; 9(2):95-102. PubMed ID: 36196453
    [No Abstract]   [Full Text] [Related]  

  • 19. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial.
    Prymula R; Bergsaker MR; Esposito S; Gothefors L; Man S; Snegova N; Štefkovičova M; Usonis V; Wysocki J; Douha M; Vassilev V; Nicholson O; Innis BL; Willems P
    Lancet; 2014 Apr; 383(9925):1313-1324. PubMed ID: 24485548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.